EmitBio Inc.
EmitBio is a life science company developing breakthrough medical devices that change how the world treats respiratory infectious disease. They focus on drug-free, light-based antiviral treatments, particularly for COVID-19 and other respiratory diseases, aiming to provide safe, effective, and non-chemical treatment options.
Industries
Nr. of Employees
small (1-50)
EmitBio Inc.
Products
At-home oropharyngeal light therapy device (investigational)
A handheld, investigational medical device that delivers controlled visible light to the oropharynx intended to inactivate respiratory viruses and reduce symptom duration in mild respiratory infections.
At-home oropharyngeal light therapy device (investigational)
A handheld, investigational medical device that delivers controlled visible light to the oropharynx intended to inactivate respiratory viruses and reduce symptom duration in mild respiratory infections.
Services
Design and operation of outpatient and at-home clinical studies including enrollment, randomized sham-controlled trials, and safety/efficacy endpoints.
Laboratory evaluation of light dosing on viral inactivation and tissue tolerability using human airway epithelial models and virology assays.
Preparation and management of regulatory submissions and registrations for medical devices across device classes and special pathways.
End-to-end device engineering services from concept, prototyping, and design validation toward commercialization readiness.
Operational services for global supply chain management, manufacturing planning, and new product introduction for medical devices.
Preparation of peer-reviewed manuscripts, conference presentations, and press releases to communicate preclinical and clinical results.
Design and operation of outpatient and at-home clinical studies including enrollment, randomized sham-controlled trials, and safety/efficacy endpoints.
Laboratory evaluation of light dosing on viral inactivation and tissue tolerability using human airway epithelial models and virology assays.
Preparation and management of regulatory submissions and registrations for medical devices across device classes and special pathways.
End-to-end device engineering services from concept, prototyping, and design validation toward commercialization readiness.
Operational services for global supply chain management, manufacturing planning, and new product introduction for medical devices.
Preparation of peer-reviewed manuscripts, conference presentations, and press releases to communicate preclinical and clinical results.
Expertise Areas
- Light-based antiviral therapeutics
- Clinical trial management (Phases I–III)
- Medical device engineering and commercialization
- Regulatory strategy and device registration
Key Technologies
- Visible blue light phototherapy (~425 nm)
- Targeted oropharyngeal light delivery systems
- LED-based handheld medical devices
- Human airway epithelial in vitro models
News & Updates
A publication by the American Society for Microbiology in May 2025 discussing the potential of 425 nm light to inactivate SARS-CoV-2 variants and reduce viral titers in human airway epithelial cells.
A news article about EmitBio's presentation at the World Congress on Infectious Diseases in October 2023.
A news article from WRAL TechWire in February 2022 discussing the potential for at-home COVID-19 treatment using EmitBio's blue light technology.
EmitBio's technology demonstrated a 99.99% reduction of Delta variant in human tissue.
A publication by the American Society for Microbiology in May 2025 discussing the potential of 425 nm light to inactivate SARS-CoV-2 variants and reduce viral titers in human airway epithelial cells.
A news article about EmitBio's presentation at the World Congress on Infectious Diseases in October 2023.
A news article from WRAL TechWire in February 2022 discussing the potential for at-home COVID-19 treatment using EmitBio's blue light technology.
EmitBio's technology demonstrated a 99.99% reduction of Delta variant in human tissue.